• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

$995.00 – $1,990.00

Clear
SKU: KLI5310061 Category: Diagnostics Market Research Pages: 298
  • Description
  • Table of Contents
  • Latest reports

Description

Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)

Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment.

This report explains events in the market and provides lists of companion products. It also provides market sizing and forecasts models for companies engaged in the market or those who are assessing its potential.

This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information, with forecasts to 2018

Infectious Disease
Neurological Disorders
Oncology
Blood
Metabolic
Cardiovascular

The situation with compainion diagnotics is fluid. Uptake was because companion tests lacked FDA approval, which prevented promotion But the realization that companion diagnostics can cut costs will most likely benefit from a therapy and ruling out those therapies has ensured a pathway.

There are many competitors in the market which include large multiproduct companies such as Siemens, Roche and Beckman Coulter and small niche developers such as Diagenic 20/20 GeneSystems.

Companies profiles in this report include:

  • 20/20 GeneSystems
  • Abbott Laboratories
  • Affymetrix
  • Agendia
  • Alere
  • Beckman Coulter
  • Becton Dickinson
  • Biocartis SA
  • Biodesix
  • bioMerieux
  • BioReference Laboratory
  • bioTheranostics
  • CardioDX
  • Celera Alameda
  • Clarient
  • deCODE Genetics
  • DiaGenic
  • Genomic Health
  • Genoptix Medical Laboratory
  • Illumina
  • Johnson & Johnson
  • Life Techologies
  • Memory Dx
  • Myriad Genetics
  • Nanostring Technologies
  • OPKO Health
  • Provista Dx
  • Qiagen
  • Roche
  • Seimens Healthcare
  • Singulex
  • Thermo Fisher Scientific

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from secondary sources and interviews with experts. including research scientists, business development managers and marketing managers.microbiologists, pathologists, hospital authorities and reimbursement specialists.

Table of Contents

ONE: EXECUTIVE SUMMARY

Overview

Scope and Methodology

Total Size and Growth of the Market

Issues and Trends Affecting Market

Leading Competitors

TWO: INTRODUCTION TO THE COMPANION DIAGNOSTICS INDUSTRY

Overview

Biomarkers

Types of Biomarkers

Biomarkers as Treatment Selection Tool

Biomarkers as Therapy Monitoring Tool

Personalized Medicine

Potential Benefits

Privacy and Public Perception

THREE: INDUSTRY TRENDS

The Health Industry

Population Demographics

Life Expectancy

Chronic Disease Impact

Disease and An Aging Population

Healthcare Reform in the United States

Co-Development and Partnership Deals

Companion Diagnostic Business Model

Reimbursement Issues

Antimicrobial Drug Resistance

BRIC Involvement

Regulatory Structure

Molecular Test Reimbursement

FOUR: COMPANION DIAGNOSTIC PRODUCTS

Cancer

Overview

Biochemistry of Cancer Cells

Carcinogen Metabolism

Causes of Cancer Growth

Environmental Factors, DNA, RNA

Cellular Oncogenes

Tumor Suppressor Genes

History of Cancer

Cancer Types

Cancer Biomarker Examples

New Developments

Cancer Companion Diagnostics

Selected Cancer Companion Diagnostics in Development

Cardiovascular

Overview

The Cardiovascular System

Heart

Circulatory System

Cardiac Cycle

Coronary Circulation

Cardiac Myocytes

Molecular Contraction

Cardiovascular and Blood Diseases

Ischemic Heart Disease

Chronic Ischemic Cardiomyopathy

Sudden Cardiac Death

Valvular and Endocardial Diseases

Mitral Valve Disorders

Aortic Valve Disorders

Rheumatic Heart Disease

Endocarditis

Pericardial Diseases

Pericardial Effusion

Pericarditis

Myocardial Diseases

Myocarditis

Cardiomyopathy

Congenital Heart Diseases

Atrial Septal Defect

Ventral Septal Defect

Pulmonary Stenosis

Aortic Stenosis

Coarctation of the Aorta

Patent Ductus Arteriosus

Truncus Arteriosus

Transposition of the Great Arteries

Tricuspid Atresia

Congestive Heart Failure

Etiology

Cardiac Dysrhythmias

Hypertension

Risk Factors

Effects of High Blood Pressure

Blood Disorders

Hyperlipidemia

Biomarker Availability

New Developments

Companion Diagnostics

Selected Cardiovascular Companion Diagnostics in Development

Endocrine, Autoimmune

Overview

The Endocrine System

Hormone Function

Hormone Synthesis

Immune System

Autoimmunity

Genetic Factors

Environmental Factors

Inflammatory Disorders

Disease Overview

Classification of Endocrine Disorders

Growth Hormone Disorders

1Etiology of Growth Hormone

Antidiuretic Hormone Disorders

Etiology

Thyroid Hormone Disorders

Hypothyroidism

Hyperthyroidism

Adrenocortical Hormone Disorders

Diabetes Mellitus

Type 1 Diabetes

Type 2 Diabetes

Rheumatic Arthritis

Biomarker Availability

New Developments

Companion Diagnostics

Infectious Disease

Overview

Infection

Infectious Diseases

HIV Disease

Hepatitis C

Human Papillomavirus (HPV)

Sepsis

Biomarker Availability

New Developments

Companion Diagnostics

Central Nervous System

Overview

The Nervous System

Central Nervous System

Peripheral Nervous System

Autonomic Nervous System

Nervous System Disorders

Alzheimer’s Disease

Multiple Sclerosis

Parkinson’s Disease

Stroke

Biomarker Examples

New Developments

Companion Diagnostics

FIVE: MARKET SIZE AND GROWTH

Market Considerations

Market Overview

Companion Diagnostics Market by Geographical Region

SIX: COMPANY PROFILES

Introduction

20/20 GeneSystems, Inc.

Company Overview

Abbott Laboratories

Company Overview

Affymetrix

Company Overview

Agendia, Inc. USA

Company Overview

Alere, Inc

Company Overview

Asuragen, Inc.

Company Overview

Beckman Coulter, Inc

Company Overview

Becton, Dickinson

Company Overview

Biocartis S.A.

Company Overview

Biodesix, Inc.

Company Overview

bioMerieux SA

Company Overview

BioReference Laboratories, Inc

Company Overview

bioTheranostics, Inc.

Company Overview

CARDIODX, INC

Company Overview

CELERA ALAMEDA

Company Overview

Clarient, Inc

Company Overview

deCODE Genetics, Inc.

Company Overview

DiaGenic ASA

Company Overview

Genomic Health, Inc.

Company Overview

Genoptix Medical Laboratory

Company Overview

Illumina, Inc.

Company Overview

Johnson & Johnson

Company Overview

Life Technologies Corporation (part of Thermo Fisher)

Company Overview

Memory Dx

Company Overview

Myriad Genetics, Inc.

Company Overview

Nanostring Technologies, Inc.

Company Overview

OPKO Health, Inc.

Company Overview

Provista Dx

Company Overview

Qiagen N.V.

Company Overview

Roche

Company Overview

SIEMENS HEALTHCARE

Company Overview

Singulex, Inc

Company Overview

Thermo Fisher Scientific

Company Overview

APPENDIX: LIST OF CONTRIBUTORS

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats, Volumes I – III

    $3,995.00 – $7,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
World Market for Clinical Nutrition Products: Forecasts to 2021 (Infant, Parenteral...The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition
Scroll to top